Skip to main content
Log in

Study of the mechanism of acupuncture and moxibustion in protecting the intestinal mucosal barrier in DSS-induced UC rats based on the IL-9/IL-9R pathway

基于IL-9/IL-9R途径研究针灸保护DSS诱导的UC大鼠肠黏膜屏障的作用机制

  • Basic Study
  • Published:
Journal of Acupuncture and Tuina Science Aims and scope Submit manuscript

Abstract

Objective

To observe the effects of acupuncture and moxibustion on interleukin (IL)-9/IL-9 receptor (IL-9R) in the colon tissue of rats with ulcerative colitis (UC) and investigate the protective mechanism of acupuncture and moxibustion on the intestinal mucosal barrier in UC rats.

Methods

Male Sprague-Dawley rats were randomly divided into a normal control (NC) group and a modeling group. UC models were prepared by giving 4% dextran sulfate sodium (DSS) water for 7 d. After the successful construction of the UC rat model, the modeling group was randomly divided into a UC group, a herb-partitioned moxibustion (HM) group, and an electroacupuncture (EA) group. HM and EA interventions at bilateral Tianshu (ST25) were performed once a day for 7 d. Hematoxylin-eosin (HE) staining was used to observe the histopathological changes in the colon. The serum concentrations of IL-9, IL-6, IL-1β, and hemoglobin-H (HbH) were determined by enzyme-linked immunosorbent assay. The protein expression levels of IL-9, IL-9R, Claudin-2, zonula occludens-1 (ZO-1), and occludin in the colon tissue were measured by Western blotting or immunohistochemistry. Immunofluorescence was used to detect the co-expression of PU.1 and CD4 with the IL-9 protein.

Results

Compared with the NC group, the colon tissue of UC rats was severely damaged and ulcerated with congestion and edema, and the colonic histopathological score increased significantly (P<0.01). The serum HbH concentration decreased significantly (P<0.01), while the serum concentrations of IL-9, IL-6, and IL-1β increased (P<0.01). The protein expression of colonic ZO-1 and occludin decreased significantly (P<0.01), while the protein expression of colonic IL-9 and IL-9R increased (P<0.05). The positive co-expression levels of IL-9/PU.1 and IL-9/CD4 increased in the colon tissue (P<0.05). Compared with the UC group, the colonic mucosal structures were gradually repaired in both HM group and EA group, and healed ulcers could be observed, the colonic histopathological score decreased significantly (P<0.05). The serum concentration of HbH increased (P<0.01), while the serum concentrations of IL-9, IL-6, and IL-1β decreased (P<0.05). The protein expression levels of ZO-1 and occludin increased (P<0.05), while the protein expression levels of IL-9 and IL-9R decreased (P<0.01). The positive co-expression levels of IL-9/PU.1 and IL-9/CD4 decreased in the colon tissue (P<0.05).

Conclusion

Both HM and EA can inhibit the protein expression levels of IL-9 and IL-9R in the UC colon by regulating the transcription factor PU.1, promote the repair of intestinal mucosal barrier, and down-regulate protein contents of proinflammatory factors IL-9, IL-6, and IL-1β in the serum, which may be one of the key mechanisms of acupuncture and moxibustion in reducing the inflammation of UC colonic mucosa and protecting the intestinal mucosal barrier.

摘要

目的

观察针灸对溃疡性结肠炎(UC)大鼠结肠组织肠黏膜白细胞介素(IL)-9/IL-9 受体(IL-9R)的调节作 用, 探讨针灸对UC 大鼠肠黏膜屏障的保护机制。

方法

将雄性Sprague-Dawley 大鼠随机分为正常组和造 模组。造模组先予以4%葡聚糖硫酸钠(DSS)水溶液连续自由饮用7 d。大鼠UC 模型构建成功后, 将造模组 大鼠随机分为模型组、隔药灸组和电针组。隔药灸组和电针组分别接受隔药灸和电针双侧天枢穴干预, 每 日1 次, 连续干预7 d。采用苏木素-伊红(HE)染色法观察大鼠结肠组织病理学变化并评分; 采用酶联免疫吸 附测定法测定血清中IL-9、IL-6、IL-1β 和血红蛋白H(HbH)的蛋白含量; 采用免疫印迹法或免疫组化法检测 大鼠结肠组织IL-9、IL-9R、Claudin-2、紧密连接蛋白1(ZO-1)和Occludin 的蛋白表达; 采用免疫荧光法检测 PU.1、CD4 与IL-9 蛋白共表达。

结果

与正常组比较, 模型组大鼠结肠组织损伤严重, 出现大面积的溃疡, 伴有充血水肿, 结肠组织病理学评分显著升高(P<0.01), 血清HbH 浓度降低(P<0.01), 血清中IL-9、IL-6 和IL-1β 蛋白含量均升高 (P<0.01), 结肠组织中ZO-1 和Occludin 蛋白表达降低(P<0.01), 结肠组织中IL-9、IL-9R 蛋白表达均增高(P<0.05), 结肠组织中IL-9/PU.1 和IL-9/CD4 阳性共表达增加(P<0.05)。与模型组相比, 隔药 灸组和电针组大鼠结肠黏膜结构逐渐修复, 可见愈合性溃疡, 结肠组织病理学评分降低(P<0.05), 血清HbH 浓度增加(P<0.01), 血清IL-9、IL-6 和IL-1β 蛋白含量均降低(P<0.05), 结肠组织中ZO-1 和Occludin 蛋白表达 升高 (P<0.05), 结肠组织中IL-9、IL-9R 蛋白表达降低(P<0.01), 结肠组织中IL-9/PU.1 和IL-9/CD4 阳性共表达 降低(P<0.05)。

结论

隔药灸和电针均能通过调节转录因子PU.1 抑制UC 结肠组织中IL-9 与IL-9R 的蛋白表 达, 促进肠黏膜屏障修复, 降低血清中促炎因子IL-9、IL-6 和IL-1β 的蛋白含量, 这可能是针灸减轻UC 结肠 黏膜炎症, 保护肠黏膜屏障的关键机制之一。

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. VENTHAM N T, KENNEDY N A, NIMMO E R, SATSANGI J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology, 2013, 145(2): 293–308.

    Article  CAS  PubMed  Google Scholar 

  2. MAK W Y, ZHAO M, NG S C, BURISCH J. The epidemiology of inflammatory bowel disease: East meets West. J Gastroenterol Hepatol, 2020, 35(3): 380–389.

    Article  PubMed  Google Scholar 

  3. ROGLER G. Chronic ulcerative colitis and colorectal cancer. Cancer Lett, 2014, 345(2): 235–241.

    Article  CAS  PubMed  Google Scholar 

  4. LI W, XU W. Progress of traditional Chinese medicine in the treatment of ulcerative colitis. Jinzhou Yike Daxue Xuebao, 2022, 43(2): 108–112.

    CAS  Google Scholar 

  5. LI H, LI K S, WU L Y, ZHOU Z G, HUANG R J, WU H G, LIU Y N, HUANG Y, MA X P, LIU H R, LU Y. Effect of moxibustion on vitamin D receptor and p53 signaling pathway in ulcerative colitis rats. Shijie Zhongyiyao, 2020, 15(15): 2259–2263, 2270.

    CAS  Google Scholar 

  6. WU H G, HUANG Z, LIU H R, ZHANG W, SHI Y, ZHU Y, CUI Y H, LIU S M. Experimental study on influence of acupuncture and moxibustion therapy on apoptosis of colonic epithelial cells in rats of ulcerative colitis. Zhongguo Zhen Jiu, 2005, 25(2): 119–122.

    PubMed  Google Scholar 

  7. SHEN Y, CUI Y H, SHI Z, WU H G, WANG Z Q, WU L Y, LU Y, HUANG Y, LIU Y N, LONG J Y, LIN Y Y, MA Z. Investigating the influence of moxibustion on colonic mucosal barrier in rats with dextran sulfate sodium-induced ulcerative colitis. J Acupunct Tuina Sci, 2022, 20(1): 1–11.

    Article  Google Scholar 

  8. JIA W R, LIU Q G, WEI W, SU X L, YANG J Q, WANG X, ZHEN J H, FENG Y Y, JIANG H X, HUANG G R. Progress of research on mechanism of acupuncture and moxibustion treating ulcerative colitis. Huanqiu Zhongyiyao, 2021, 14(10): 1912–1916.

    CAS  Google Scholar 

  9. CHEN S J, LIU X W, LIU J P, YANG X Y, LU F G. Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier. World J Gastroenterol, 2014, 20(28): 9468–9475.

    Article  PubMed  PubMed Central  Google Scholar 

  10. NI J, SHEN T D, CHEN E Z, BITTINGER K, BAILEY A, ROGGIANI M, SIROTA-MADI A, FRIEDMAN E S, CHAU L, LIN A, NISSIM I, SCOTT J, LAUDER A, HOFFMANN C, RIVAS G, ALBENBERG L, BALDASSANO R N, BRAUN J, XAVIER R J, CLISH C B, YUDKOFF M, LI H, GOULIAN M, BUSHMAN F D, LEWIS J D, WU G D. A role for bacterial urease in gut dysbiosis and Crohn’s disease. Sci Transl Med, 2017, 9(416): eaah6888.

    Article  PubMed  PubMed Central  Google Scholar 

  11. UNGARO R, MEHANDRU S, ALLEN P B, PEYRIN-BIROULET L, COLOMBEL J F. Ulcerative colitis. Lancet, 2017, 389(10080): 1756–1770.

    Article  PubMed  Google Scholar 

  12. GERLACH K, MCKENZIE A N, NEURATH M F, WEIGMANN B. IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis. Tissue Barriers, 2015, 3(1–2): e983777.

    Article  PubMed  PubMed Central  Google Scholar 

  13. NEURATH M F, FINOTTO S. IL-9 signaling as key driver of chronic inflammation in mucosal immunity. Cytokine Growth Factor Rev, 2016, 29: 93–99.

    Article  CAS  PubMed  Google Scholar 

  14. GERLACH K, HWANG Y, NIKOLAEV A, ATREYA R, DORNHOFF H, STEINER S, LEHR H A, WIRTZ S, VIETH M, WAISMAN A, ROSENBAUER F, MCKENZIE A N, WEIGMANN B, NEURATH M F. Th9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol, 2014, 15(7): 676–686.

    Article  CAS  PubMed  Google Scholar 

  15. CHEAH K Y, BASTIAN S E, ACOTT T M, ABIMOSLEH S M, LYMN K A, HOWARTH G S. Grape seed extract reduces the severity of selected disease markers in the proximal colon of dextran sulphate sodium-induced colitis in rats. Dig Dis Sci, 2013, 58(4): 970–977.

    Article  PubMed  Google Scholar 

  16. HUANG Y, MA Z, CUI Y H, DONG H S, ZHAO J M, DOU C Z, LIU H R, LI J, WU H G. Effects of herb-partitioned moxibustion on the miRNA expression profiles in colon from rats with DSS-induced ulcerative colitis. Evid Based Complement Alternat Med, 2017, 2017: 1767301.

    Article  PubMed  PubMed Central  Google Scholar 

  17. YU S G, XU B. Experimental Acupuncture Science. 2nd Edition. Beijing: People’s Medical Publishing House, 2016.

    Google Scholar 

  18. OBERMEIER F, DUNGER N, STRAUCH U G, GRUNWALD N, HERFARTH H, SCHÖLMERICH J, FALK W. Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin Exp Immunol, 2003, 134(2): 217–224.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. LI R J, ZENG J M, LI J X. Discussion on Tianshu point from “Acupuncture and Moxibustion” and analysis of its contemporary clinical application law. Zhongyiyao Linchuang Zazhi, 2022, 34(6): 1023–1027.

    Google Scholar 

  20. ZHOU E H, LIU H R, WU H G, SHI Z, ZHANG W, ZHU Y, SHI D R, ZHOU S. Down-regulation of protein and mRNA expression of IL-8 and ICAM-1 in colon tissue of ulcerative colitis patients by partition-herb moxibustion. Dig Dis Sci, 2009, 54(10): 2198–2206.

    Article  PubMed  Google Scholar 

  21. ZENG Y H, LIN L Z, WU X Y, WU F. Effect of acupuncture on ulcerative colitis in rats based on the TGF-β/Smad7 signaling pathway. Zhongyiyao Tongbao, 2022, 21(10): 50–54.

    Google Scholar 

  22. WANG C L, HE L F, ZHANG J, OUYANG C H, WU X P, LU F G, LIU X W. Clinical, laboratory, endoscopical and histological characteristics predict severe ulcerative colitis. Hepatogastroenterology, 2013, 60(122): 318–323.

    PubMed  Google Scholar 

  23. KAMINSKY L W, AL-SADI R, MA T Y. IL-1β and the intestinal epithelial tight junction barrier. Front Immunol, 2021, 12: 767456.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. WEIGMANN B, NEURATH M F. Th9 cells in inflammatory bowel diseases. Semin Immunopathol, 2017, 39(1): 89–95.

    Article  CAS  PubMed  Google Scholar 

  25. MATUSIEWICZ M, NEUBAUER K, BEDNARZ-MISA I, GORSKA S, KRZYSTEK-KORPACKA M. Systemic interleukin-9 in inflammatory bowel disease: association with mucosal healing in ulcerative colitis. World J Gastroenterol, 2017, 23(22): 4039–4046.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. SHOHAN M, ELAHI S, SHIRZAD H, RAFIEIAN-KOPAEI M, BAGHERI N, SOLTANI E. Th9 cells: probable players in ulcerative colitis pathogenesis. Int Rev Immunol, 2018, 37(4): 192–205.

    Article  CAS  PubMed  Google Scholar 

  27. QU D D. The Expression and Significance of Interleukin-9, Interleukin-6 and Tumor Necrosis Factor-α in the Colonic Mucosa of Patients with Ulcerative Colitis. Binzhou: Master Thesis of Binzhou Medical University, 2017.

    Google Scholar 

  28. ZHOU S, XU C D, CHEN S N. Composition and protective factors of intestinal mucosal barrier. Guowai Yixue: Erkexue Fence, 2004, 31(S1): 60–62.

    Google Scholar 

  29. ZEISEL M B, DHAWAN P, BAUMERT T F. Tight junction proteins in gastrointestinal and liver disease. Gut, 2019, 68(3): 547–561.

    Article  CAS  PubMed  Google Scholar 

  30. LUETTIG J, ROSENTHAL R, BARMEYER C, SCHULZKE J D. Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation. Tissue Barriers, 2015, 3(1–2): e977176.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. DU J, CHEN Y, SHI Y, LIU T, CAO Y, TANG Y, GE X, NIE H, ZHENG C, LI Y C. 1,25-dihydroxyvitamin D protects intestinal epithelial barrier by regulating the myosin light chain kinase signaling pathway. Inflamm Bowel Dis, 2015, 21(11): 2495–2506.

    Article  PubMed  Google Scholar 

  32. AMASHEH S, DULLAT S, FROMM M, SCHULZKE J D, BUHR H J, KROESEN A J. Inflamed pouch mucosa possesses altered tight junctions indicating recurrence of inflammatory bowel disease. Int J Colorectal Dis, 2009, 24(10): 1149–1156.

    Article  PubMed  Google Scholar 

  33. PRASAD S, MINGRINO R, KAUKINEN K, HAYES K L, POWELL R M, MACDONALD T T, COLLINS J E. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest, 2005, 85(9): 1139–1162.

    Article  CAS  PubMed  Google Scholar 

  34. ZEISSIG S, BÜRGEL N, GÜNZEL D, RICHTER J, MANKERTZ J, WAHNSCHAFFE U, KROESEN A J, ZEITZ M, FROMM M, SCHULZKE J D. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut, 2007, 56(1): 61–72.

    Article  CAS  PubMed  Google Scholar 

  35. WANG Y, BI Y, CHEN X, LI C, LI Y, ZHANG Z, WANG J, LU Y, YU Q, SU H, YANG H, LIU G. Histone deacetylase SIRT1 negatively regulates the differentiation of interleukin-9-producing CD4+ T cells. Immunity, 2016, 44(6): 1337–1349.

    Article  CAS  PubMed  Google Scholar 

  36. CHEN J, GUAN L, TANG L, LIU S, ZHOU Y, CHEN C, HE Z, XU L. T helper 9 cells: a new player in immune-related diseases. DNA Cell Biol, 2019, 38(10): 1040–1047.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. KAPLAN M H. Th9 cells: differentiation and disease. Immunol Rev, 2013, 252(1): 104–115.

    Article  PubMed  PubMed Central  Google Scholar 

  38. QU D D, JIN S L, HU Z B. Research progress of IL-9/Th9 and ulcerative colitis. Zhongguo Dangdai Yiyao, 2016, 23(18): 19–21.

    Google Scholar 

  39. WU M Y, WANG D, LI H, ZHANG X L. Th9 cells with IL-9 and their role in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi, 2018, 26(20): 1263–1267

    Google Scholar 

  40. TIAN L L, LI Y, ZHANG J, CHANG R Q, LI J H, HUO L J. IL-9 promotes the pathogenesis of ulcerative colitis through STAT3/SOCS3 signaling. Biosci Rep, 2018, 38(6): BSR20181521.

    Article  PubMed  PubMed Central  Google Scholar 

  41. NALLEWEG N, CHIRIAC M T, PODSTAWA E, LEHMANN C, RAU T T, ATREYA R, KRAUSS E, HUNDORFEAN G, FICHTNER-FEIGL S, HARTMANN A, BECKER C, MUDTER J. IL-9 and its receptor are predominantly involved in the pathogenesis of UC. Gut, 2015, 64(5): 743–755.

    Article  CAS  PubMed  Google Scholar 

  42. CHANG H C, SEHRA S, GOSWAMI R, YAO W, YU Q, STRITESKY G L, JABEEN R, MCKINLEY C, AHYI A N, HAN L, NGUYEN E T, ROBERTSON M J, PERUMAL N B, TEPPER R S, NUTT S L, KAPLAN M H. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nature Immunol, 2010, 11(6): 527–534.

    Article  CAS  Google Scholar 

  43. KOH B, HUFFORD M M, PHAM D, OLSON M R, WU T, JABEEN R, SUN X, KAPLAN M H. The ETS family transcription factors ETV5 and PU.1 function in parallel to promote Th9 cell development. J Immunol, 2016, 197(6): 2465–2472.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Projects of National Natural Science Foundation of China (国家自然科学基金 项目, No. 82174501, No. 82105012, No. 82004475, No. 81873372); Shanghai Municipal Natural Science Foundation (上海市自然科学基金项目, No. 21ZR1460200, No. 22ZR1458400); Shanghai Talent Development Fund Project (上海市人才发展基金项目, No. 2021058); One Hundred Person Project of Xinglin of Shanghai University of Traditional Chinese Medicine (上海中医药大学“杏林 百人计划”项目, No. [2020] 23).

Author information

Authors and Affiliations

Authors

Contributions

HUANG Yan, HUANG Rude, and WU Luyi designed the study; HUANG Yan and SUN Kexin finished experiments and wrote the manuscript; MA Zhe, ZHAO Jimeng, ZHAO Chen, and YANG Ling performed partial research; LI Feng, LIU Yanan, and ZHANG Yue analyzed the data; XU Jing and LI Lingjie helped revise the manuscript.

Corresponding authors

Correspondence to Luyi Wu  (吴璐一) or Rude Huang  (黄儒德).

Ethics declarations

Conflict of Interest

The authors declare that there is no potential conflict of interest in this article.

Statement of Human and Animal Rights

All experimental operations were conducted under the guidance of the Animal Ethics Committee of Shanghai University of Traditional Chinese Medicine. The treatment of animals in this experiment conformed to the ethical criteria.

Additional information

Co-first Authors: HUANG Yan, M.D., associate researcher; SUN Kexin, master degree candidate

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, Y., Sun, K., Xu, J. et al. Study of the mechanism of acupuncture and moxibustion in protecting the intestinal mucosal barrier in DSS-induced UC rats based on the IL-9/IL-9R pathway. J. Acupunct. Tuina. Sci. 22, 91–103 (2024). https://doi.org/10.1007/s11726-024-1424-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11726-024-1424-6

Keywords

关键词

中图分类号

文献标志码

Navigation